A federal judge presiding over 6,000 testosterone lawsuits has scheduled the first trial involving Eli Lilly's Axiron for January 28, 2018.
A jury in Illinois has found AbbVie Inc. responsible for failing to warn about the heart attack risks of the "Low T" testosterone gel AndroGel.
Men who start testosterone therapy are 63% more likely to have a Venous Thromboembolism (VTE) in the first 6 months of treatment, with the risk peaking at 3 months. Over 6,300 lawsuits have been filed by men who were injured...
Men who take testosterone supplements for cardiovascular, sexual and physical function aren’t likely to see any benefits, according to a new study published in the medical journal PLOS ONE.